EMA's Proposal To Disclose Key Elements Of Pediatric Plans On Hold For Now

 
• By Vibha Sharma

A year after the European Medicines Agency announced plans to publicly disclose the key elements of pediatric investigation plans to make its regulatory decisions more transparent, concerns around confidentiality issues and resources means no final decision has yet been made on the implementation of this controversial proposal.

Business Pro Con_1200
EMA Is Still Weighing Up The Implications Of Its PIP Transparency Proposal • Source: Shutterstock

More from Clinical Trials

More from R&D